Clinical trials
Phase 3 Purpura, Thrombocytopenic, Idiopathic trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| argenx | 4 |
| GlaxoSmithKline | 2 |
| Novartis Pharmaceuticals | 2 |
| Takeda | 2 |
| UCB Biopharma SRL | 2 |
| Kissei Pharmaceutical Co., Ltd. | 1 |
| Principia Biopharma, a Sanofi Company | 1 |
| Sanofi | 1 |
| Sobi, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 16 |
| Autoimmune Diseases | 2 |
| Blood Platelet Disorders | 2 |
| Cytopenia | 2 |
| Hematologic Diseases | 2 |
| Hemorrhage | 2 |
| Hemorrhagic Disorders | 2 |
| Immune System Diseases | 2 |
| Purpura | 2 |
| Purpura, Thrombocytopenic | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.